Technology | Oncology Information Management Systems (OIMS) | July 15, 2019

RaySearch Releases Version 3A of RayCare Oncology Information System

New features include RayCare Flow to connect RayStation treatment planning system with workflow management capabilities of RayCare and RayCare PACS

RaySearch Releases Version 3A of RayCare Oncology Information System

July 15, 2019 — RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is designed to support the workflow in a modern oncology center, connecting the different oncology disciplines, boosting efficiency and ensuring optimal use of resources. RayCare is being continually developed in collaboration with some of the leading cancer centers worldwide, according to RaySearch.

RayCare is now in clinical use at three centers worldwide. The most recent addition is Heidelberg University Hospital in Germany, who started using RayCare clinically in May 2019. The other two centers have been using RayCare since 2018, first at Iridium Cancer Network in Belgium, and at Provision Cares Proton Therapy Center in Nashville. RaySearch said the release of RayCare 3A is the first of this year`s two major versions.

RayCare 3A brings several new features to support the efficiency and workload control for radiation therapy users. The enhanced ‘Home’ workspace provides a comprehensive overview for each user’s activities, including new features such as task statistics to guide daily priorities and the option to pin tasks of interest. The RayCare workflow engine now supports modular patient workflows. This advanced feature enables the evolution of the patient workflow by adding modules of tasks when different clinical decision points are reached. The modularization of the digital workflows makes it possible to tailor the workflows to the specific patient needs and further streamline the flow of the clinic.

It also adds the patient chart summary feature that provides an at-a-glance patient-centered overview and a hub for quick navigation to important workspaces. It will also be possible to automatically trigger plan generation protocols in RayStation from RayCare, based on availability of image data. Furthermore, there are usability and performance enhancements throughout the product as well as extended connectivity with other hospital systems.  

RayCare 3A introduces RayCare Flow, a feature package designed to connect the RayStation treatment planning system with the workflow management capabilities of RayCare and RayCare PACS (picture archiving and communication system). RayCare Flow optimizes the treatment planning process by providing automated task management for all the steps in the planning workflow. With this solution, RayCare becomes the environment from which treatment planning is coordinated and managed. To support resource management and workload visibility of planning tasks, RayCare Flow includes an interactive real-time planning whiteboard. RayCare Flow can improve resource management, increase efficiency of treatment planning workflow and capture all clinical communications, as well as automate image management.

For more information: www.raysearchlabs.com

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

Professor David Sebag-Montefiore (Image courtesy of the University of Leeds)

News | Radiation Therapy | April 07, 2020
April 7, 2020 — An intern...
Eclipse v16 has received CE mark and is 510(k) pending
News | Proton Therapy | April 06, 2020
April 6, 2020 — Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technolo
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Feature | Radiation Dose Management | April 02, 2020 | By Melinda Taschetta-Millane
Rising concerns over...
Women are more likely to be cured of cancer by radiotherapy but the side effects are worse.

Women are more likely to be cured of cancer by radiotherapy but the side effects are worse. Image by Mark Kostich

News | Radiation Therapy | March 30, 2020
March 30, 2020 — Women undergoing radiotherapy for
A new framework from an international team of experts aims to help protect patients and providers, and conserve protective equipment for frontline healthcare workers #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Prostate Cancer | March 30, 2020
March 30, 2020 — In the wake of the COVID-19 pan
Novel scanners may open door for prognostic assessment in patients receiving cochlear implants

Iva Speck, MD, explains research showing that novel, fully digital, high-resolution positron emission tomography/computed tomography imaging of small brain stem nuclei can provide clinicians with valuable information concerning the auditory pathway in patients with hearing impairment. The research is featured in The Journal of Nuclear Medicine (read more at http://jnm.snmjournals.org/content/current). Video courtesy of Iva Speck, University Hospital Freiburg, Germany.

News | PET-CT | March 26, 2020
March 26, 2020 — Novel, fully digital, high-resolution...
Age‐standardized, delay‐adjusted overall cancer incidence rates for 2012 through 2016 are illustrated among males and females by racial/ethnic group

Age‐standardized, delay‐adjusted overall cancer incidence rates for 2012 through 2016 are illustrated among males and females by racial/ethnic group. Racial/ethnic groups are mutually exclusive. Data for the non‐Hispanic American Indian/Alaska Native (AI/AN) population are restricted to Indian Health Service Purchased/Referred Care Delivery Area (PRCDA) counties. API indicates Asian/Pacific Islander. Chart courtesy of ACS Journals 

News | Radiation Oncology | March 16, 2020
March 16, 2020 — The Ann...